Nanotechnology has revolutionized dentistry by transforming how oral health care is conceptualized, delivered, and maintained. Harnessing nanomaterials and advanced clinical instruments has opened new avenues for precision and innovation across various aspects of dental care. Nanotechnology offers the potential for precise pain management, tooth restoration, and alleviating dental hypersensitivity. Nanomaterials can occlude exposed dentinal tubules, enhancing patient comfort and overall oral well-being. Orthodontic therapy is also revolutionized by nanomaterials with shape memory properties, enabling rapid and more efficient tooth movement. The development of groundbreaking products and therapeutic alternatives is supported by ongoing research efforts, enabling the formation of dental implants, fillings, and prosthetic devices that closely mimic natural tooth characteristics. Nano-delivery systems are being devised for precise drug delivery within the oral cavity, ensuring optimal therapeutic outcomes with minimal side effects. The integration of nanotechnology in dentistry represents a groundbreaking evolution beyond the conventional boundaries of oral health care, enabling the development of innovative diagnostic techniques and improved oral well-being.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621876 | PMC |
http://dx.doi.org/10.7759/cureus.46423 | DOI Listing |
PLoS One
January 2025
Department of Microbiology and Hygiene, Mymensingh, Bangladesh.
Pseudomonas aeruginosa (P. aeruginosa) is a major pathogen associated conditions like septicaemia, respiratory disorders, and diarrhoea in poultry, particularly in Japanese quail (Coturnix japonica). The infection causes huge economical losses due to its high transmissibility, mortality and zoonotic potential.
View Article and Find Full Text PDFPLoS One
January 2025
Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Background: Diabetes mellitus (DM) is a global health problem. Adherence to intensive insulin therapy is necessary to achieve better glycemic control in types 1 and 2 DM. This study aimed to evaluate the extent of adherence to insulin therapy, its predictors and to identify barriers to its adherence.
View Article and Find Full Text PDFPLoS One
January 2025
Substitutive Dental Sciences Department (Prosthodontics), College of Dentistry, Taibah University, Al Madinah, Saudi Arabia.
Background: This study aimed to investigate the quality and readability of online English health information about dental sensitivity and how patients evaluate and utilize these web-based information.
Methods: The credibility and readability of health information was obtained from three search engines. We conducted searches in "incognito" mode to reduce the possibility of biases.
PLoS One
January 2025
Nova School of Business and Economics, Universidade Nova de Lisboa, Carcavelos, Portugal.
This empirical study assessed the potential of developing a machine-learning model to identify children and adolescents with poor oral health using only self-reported survey data. Such a model could enable scalable and cost-effective screening and targeted interventions, optimizing limited resources to improve oral health outcomes. To train and test the model, we used data from 2,133 students attending schools in a Portuguese municipality.
View Article and Find Full Text PDFScand J Clin Lab Invest
January 2025
Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Background: Direct oral anticoagulants (DOACs) can interfere with coagulation analyses, causing erroneous results such as false-positive lupus anticoagulant and false-normal antithrombin, threatening patient safety when overlooked. A test using a prothrombin time quotient method to detect DOAC presence in plasma samples is now commercially available, the MRX PT DOAC, with the result expressed as Clot Time Ratio (CTR).
Objectives: Evaluate the ability of MRX PT DOAC to identify interfering apixaban or rivaroxaban concentrations, identify non-interfering or interfering patient samples, and detect whether a patient is on DOAC treatment.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!